Clinical Trials Browser

Has results × Carcinoma, Non-Small-Cell Lung × etirinotecan pegol × Clear all

NCT02312622 2023-12-12

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Phase 2 Completed

27 enrolled 19 charts

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT01773109 2020-04-03

Etirinotecan Pegol (NKTR-102) in NSCLC

Phase 2 Completed

40 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis